欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	SK/H/0245/003
药品名称	Olanzapin Actavis
活性成分	olanzapine 15.0 mg
剂型	Orodispersible tablet
上市许可持有人	Actavis Group PTC ehf. Reykjavikurvegi 76-78 220 Hafnarfjördur Iceland
参考成员国 - 产品名称	Slovakia (SK)
互认成员国 - 产品名称	Lithuania (LT) Olanzapine Actavis 15 mg burnoje disperguojamosios tabletės Estonia (EE) RIBIDRON
许可日期	2008/05/28
最近更新日期	2023/09/20
药物ATC编码	N05AH03 olanzapine
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载	Final PL \| Olanzapine-SK_H_0245_001-004_IB_032-Label (OuP+ImP)_cleanDate of last change:2020/07/07 Final PL \| Olanzapine-SK_H_0245_001-004_IB_032-Label (OuP+ImP)_trackedDate of last change:2020/07/07 Final PL \| Olanzapine-SK_H_0245_001-004_IB_032-PIL_cleanDate of last change:2020/07/07 Final PL \| Olanzapine-SK_H_0245_001-004_IB_032-PIL_trackedDate of last change:2020/07/07 Final PL \| Olanzapine-SK_H_0245_001-004_IB_032-SmPC_cleanDate of last change:2020/07/07 Final PL \| Olanzapine-SK_H_0245_001-004_IB_032-SmPC_trackedDate of last change:2020/07/07 Final Product Information \| Olanzapine-SK_H_0245_001-004_IA_031-PI-final_cleaned commonDate of last change:2020/05/06 Final Product Information \| Olanzapine-SK_H_0245_001-004_IA_031-PI-final_tracked commonDate of last change:2020/05/06 Final SPC \| PI-Olanzapine-DK_H_1495_01-06_V0xx-v4.1-221116.CLDate of last change:2017/03/02
市场状态	Positive